FHIR IG analytics
Start Prev Rows 3000 - 3200 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) | Usage # |
|---|---|---|---|---|---|---|---|---|---|---|
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.146.json | Contraceptive Patch ICD10CM Provision Encounters | active | 2021-10 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.147.json | Contraceptive Patch ICD10CM Surveillance | active | 2021-10 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.148.json | Live Birth Delivery ICD10PCS Procedures | active | 2024-09 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.149.json | Contraceptive Patch HCPCS Devices | active | 2021-10 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.15.json | Chlamydia trachomatis and Neisseria Gonorrhoeae combined Tests | active | 2025-03 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.150.json | Contraceptive Patch LOINC | active | 2021-10 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.152.json | Live Birth Delivery Procedures SNOMED CT | active | 2024-09 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.153.json | Contraceptive Ring SNOMED Surveillance Procedures | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.154.json | Contraceptive Ring SNOMED Provision Procedures | active | 2021-10 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.155.json | Contraceptive Ring SNOMED Findings | active | 2021-10 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.156.json | Contraceptive Ring ICD10CM Provision Encounters | active | 2021-10 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.157.json | Contraceptive Ring ICD10CM Surveillance | active | 2021-10 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.159.json | Contraceptive Ring HCPCS Devices | active | 2022-01 | hl7 | cms | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.160.json | Contraceptive Ring LOINC | active | 2021-10 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.161.json | Contraceptive Implant SNOMED Devices | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.162.json | Contraceptive Implant ICD10PCS Provision Procedures | active | 2021-10 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.163.json | Contraceptive Implant SNOMED Provision Procedures | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.164.json | Contraceptive Implant SNOMED Findings | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.170.json | Contraceptive Implant ICD10CM Provision Encounters | active | 2021-10 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.171.json | Contraceptive Implant ICD10CM Surveillance | active | 2021-10 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.173.json | Contraceptive Implant HCPCS Devices | active | 2021-10 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.174.json | Contraceptive Patch Devices | active | 2022-03 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.177.json | Live Birth Delivery Procedures | active | 2024-09 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.178.json | Contraceptive Ring Surveillance | active | 2021-10 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.180.json | Contraceptive Implant CPT Provision Procedures | active | 2021-10 | hl7 | cpt | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.181.json | Injectable Contraceptive SNOMED Surveillance Procedures | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.182.json | Injectable Contraceptive SNOMED Provision Procedures | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.183.json | Injectable Contraceptive SNOMED Findings | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.185.json | Injectable Contraceptive ICD10CM Provision Encounters | active | 2021-10 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.186.json | Injectable Contraceptive ICD10CM Surveillance | active | 2021-10 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.187.json | Injectable Contraceptive HCPCS Provision Procedures | active | 2021-10 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.188.json | Injectable Contraceptive LOINC | active | 2021-10 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.189.json | Oral Contraceptive Pill SNOMED Surveillance Procedures | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.190.json | Oral Contraceptive Pill SNOMED Provision Procedures | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.191.json | Oral Contraceptive Pill SNOMED Findings | active | 2021-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.193.json | Oral Contraceptive Pill ICD10CM Provision Encounters | active | 2021-10 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.194.json | Oral Contraceptive Pill ICD10CM Surveillance | active | 2021-10 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.195.json | Oral Contraceptive Pill HCPCS Provision Procedures | active | 2021-10 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.196.json | Oral Contraceptive Pill LOINC | active | 2021-10 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.197.json | Injectable Contraceptive Provision Procedures | active | 2022-03 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.198.json | Injectable Contraceptive Surveillance | active | 2021-10 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.199.json | Oral Contraceptive Pill Provision Procedures | active | 2022-03 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.200.json | Oral Contraceptive Pill Surveillance | active | 2021-10 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.201.json | Contraceptive Implant Devices | active | 2022-03 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.202.json | Contraceptive Implant Provision Procedures | active | 2022-03 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.203.json | Contraceptive Implant Surveillance | active | 2021-10 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1166.96.json | Infecund Not for Contraceptive Reasons SNOMED Findings | active | 2021-10 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.10.json | ASN Screening Declined | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.2.json | Intracranial or Intraspinal surgery | active | 2022-02 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.22.json | Emergency Department Observation | active | 2024-09 | hl7 | cpt | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.27.json | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.28.json | Mental Health Diagnosis without Substance Use Disorders | active | 2025-02 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.29.json | Bed Assigned | active | 2024-05 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.3.json | Malignant Intracranial Neoplasm Group | active | 2022-03 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.31.json | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.32.json | Healthcare Agent and Power of Attorney Documentation | active | 2024-09 | hl7 | loinc | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.33.json | Advance Directive Documentation | active | 2024-10 | hl7 | loinc | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.34.json | Advance Directive Documentation | active | 2024-11 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.35.json | Advance Directive Documentation | active | 2024-09 | hl7 | cpt | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.36.json | Portable Medical Order(s) Documentation | active | 2024-10 | hl7 | loinc | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.37.json | Portable Medical Order(s) Documentation | active | 2024-09 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.38.json | Advance Care Planning Discussion Documentation | active | 2024-11 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.4.json | Thrombolytic medications | active | 2021-10 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.40.json | Advance Care Planning Documentation | active | 2024-09 | hl7 | cpt | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.41.json | Advance Care Planning Documentation | active | 2024-09 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.42.json | Healthcare Agent & Power of Attorney Documentation | active | 2024-10 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.43.json | Advance Directive Documentation | active | 2024-10 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.45.json | Advance Care Planning Documentation | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.46.json | Advance Care Planning Documentation | active | 2024-10 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.47.json | Portable Medical Order(s) Documentation | active | 2024-10 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.48.json | Portable Medical Order(s) Documentation | active | 2024-10 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.49.json | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.5.json | Allergy to thrombolytics | active | 2025-02 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.50.json | Intervention for Positive Utility Insecurity Screen | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.51.json | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.52.json | Intervention for Positive Transportation Insecurity Screen | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.53.json | Intervention for Positive Housing Instability Screen | active | 2024-11 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.54.json | Intervention for Positive Housing Instability Screen | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.55.json | Intervention for Positive Homelessness Screen | active | 2024-11 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.56.json | Intervention for Positive Homelessness Screen | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.57.json | Non Invasive Oxygen Therapy Device Codes | active | 2025-02 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.58.json | Goals, preferences, and priorities for medical treatment | active | 2025-04 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.6.json | Thrombolytics Adverse Event | active | 2025-02 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1170.7.json | Intraspinal surgery | active | 2024-02 | hl7 | cms | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1176.58.json | Food Insecurity Screening Positive | active | 2023-10 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.1.json | Ezetimibe Therapy | active | 2023-02 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.100.json | Allergy or Intolerance to ACE Medication | active | 2024-11 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.101.json | Allergy or Intolerance to ARB Medication | active | 2024-11 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.102.json | Chronic Kidney Disease Stage 1 | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.103.json | Chronic Kidney Disease Stage 2 | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.104.json | Chronic Kidney Disease Stage 3 | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.105.json | Chronic Kidney Disease Stage 4 | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.106.json | Chronic Kidney Disease Stage 5 | active | 2024-12 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.107.json | ICD10 CM Chronic Kidney Disease Stage 1 | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.108.json | ICD10 CM Chronic Kidney Disease Stage 2 | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.111.json | AHA GWTG Chronic Kidney Disease Stage 2 | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.112.json | ICD10 CM Chronic Kidney Disease Stage 3 | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.113.json | ICD10 CM Chronic Kidney Disease Stage 4 | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.114.json | ICD10 CM Chronic Kidney Disease Stage 5 | active | 2024-12 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.115.json | AHA GWTG Chronic Kidney Disease Stage 1 | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.116.json | AHA GWTG Chronic Kidney Disease Stage 3 | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.117.json | AHA GWTG Chronic Kidney Disease Stage 4 | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.118.json | SNOMED CT Atrial Fibrillation | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.119.json | ICD10 CM Atrial Fibrillation | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.121.json | AHA GWTG Atrial Fibrillation | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.123.json | SNOMED CT Hyperlipidemia | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.124.json | ICD10 CM Hyperlipidemia | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.125.json | AHA GWTG Hyperlipidemia | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.126.json | SNOMED CT Hypertriglyceridemia | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.127.json | ICD10 CM Hypertriglyceridemia | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.129.json | AHA GWTG Hypertriglyceridemia | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.130.json | SNOMED CT Gestational Diabetes | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.131.json | ICD10 CM Gestational Diabetes | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.132.json | AHA GWTG Gestational Diabetes | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.133.json | SNOMED CT Hyperglycemia | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.134.json | ICD10 CM Hyperglycemia | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.135.json | AHA GWTG Hyperglycemia | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.136.json | SNOMED CT Nonobstructive CAD | active | 2024-12 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.137.json | ICD10 CM Nonobstructive Coronary Artery Disease | active | 2024-12 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.138.json | AHA GWTG Nonobstructive coronary artery disease | active | 2024-11 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.139.json | AHA GWTG Anti Obesity Pharmacotherapy | active | 2024-12 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.15.json | Non Tobacco Smoking Product User | active | 2024-02 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.16.json | Antihypertensive Fixed Dose Combination Medications | active | 2024-02 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.2.json | PCSK9 Inhibitors | active | 2023-02 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.20.json | CCB and Thiazide and Thiazide Like Diuretics | active | 2021-01 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.21.json | Referral to cardiac rehab | active | 2021-04 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.22.json | Cardiac Rehabilitation | active | 2021-04 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.25.json | 2 Hour Blood Glucose Test | active | 2022-07 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.26.json | NYHA Functional Classification | active | 2022-07 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.27.json | ARNI Therapy | active | 2022-07 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.29.json | MRA Therapy | active | 2022-07 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.3.json | Cholesterol non HDL Laboratory Test | active | 2021-04 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.30.json | SGLT2 Inhibitors | active | 2024-02 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.31.json | Heart Transplant | active | 2022-02 | hl7 | cpt | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.32.json | Heart Transplant | active | 2022-02 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.33.json | Heart Transplant | active | 2022-02 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.34.json | Allergy to MRA Therapy | active | 2024-02 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.35.json | Aspirin or Clopidogrel | active | 2024-02 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.39.json | Cardiac Rehabilitation | active | 2024-01 | hl7 | cpt | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.4.json | Hypothyroidism | active | 2021-04 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.40.json | Cardiac Rehabilitation | active | 2022-07 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.43.json | SGLT2 Ingredients | active | 2022-07 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.44.json | MRA Ingredients | active | 2022-07 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.49.json | Minnesota Living with Heart Failure Questionnaire | active | 2022-07 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.5.json | Hypothyroidism | active | 2024-02 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.50.json | Kansas City Cardiomyopathy Questionnaire | active | 2022-07 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.51.json | Cardiac Pacer | active | 2021-11 | hl7 | cms | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.52.json | Cardiac Pacer | active | 2025-01 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.53.json | Cardiac Pacer | active | 2022-02 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.54.json | Heart Transplant Complications | active | 2022-03 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.55.json | Heart Transplant Complications | active | 2025-01 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.56.json | Heart Transplant Complications | active | 2022-03 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.57.json | Left Ventricular Assist Device Complications | active | 2022-02 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.58.json | Left Ventricular Assist Device Complications | active | 2022-02 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.59.json | Left Ventricular Assist Device Placement | active | 2023-02 | hl7 | cms | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.6.json | Hypothyroidism | active | 2021-04 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.60.json | Left Ventricular Assist Device Placement | active | 2023-02 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.61.json | Left Ventricular Assist Device Placement | active | 2022-02 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.62.json | Left Ventricular Assist Device Placement | active | 2022-02 | hl7 | cpt | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.63.json | Heart Transplant | active | 2022-07 | hl7 | cms | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.65.json | Cardiac Pacer | active | 2022-11 | hl7 | cpt | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.66.json | Diastolic Heart Failure | active | 2023-06 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.67.json | Diastolic Heart Failure | active | 2023-06 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.68.json | Diastolic Heart Failure | active | 2022-02 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.69.json | Allergy to SGLT2 Inhibitors | active | 2023-02 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.7.json | Anorexia Nervosa | active | 2023-02 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.70.json | Intolerance to SGLT2 Inhibitors | active | 2022-07 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.71.json | Intolerance to MRA Therapy | active | 2022-07 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.72.json | ARNI Ingredient | active | 2022-02 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.73.json | Mitral Stenosis | active | 2022-02 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.74.json | Mitral Stenosis | active | 2022-02 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.75.json | Mitral Stenosis | active | 2022-02 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.76.json | Mechanical Prosthetic Heart Valve | active | 2022-11 | hl7 | cpt | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.77.json | Mechanical Prosthetic Heart Valve | active | 2025-04 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.78.json | Mechanical Prosthetic Heart Valve | active | 2022-02 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.79.json | Mechanical Prosthetic Heart Valve in Situ | active | 2022-02 | hl7 | icd | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.8.json | Anorexia Nervosa | active | 2021-04 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.82.json | Systolic Heart Failure | active | 2023-03 | hl7 | icd | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.83.json | Systolic Heart Failure | active | 2023-03 | hl7 | sct | 1 | ||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.84.json | Systolic Heart Failure | active | 2023-03 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.85.json | Carotid Intervention | active | 2023-03 | hl7 | cpt | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.86.json | Serum Creatinine | active | 2023-10 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.87.json | Urine Creatinine | active | 2025-03 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.88.json | Urine Albumin | active | 2023-10 | hl7 | loinc | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.9.json | Anorexia Nervosa | active | 2021-04 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.90.json | Non Steroidal Mineralcorticoid Receptor Antagonist | active | 2024-10 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.91.json | Glucagon like peptide 1 medications | active | 2024-11 | hl7 | rx | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1178.96.json | AHA GWTG Long COVID19 | active | 2024-10 | hl7 | vsac | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.1.json | Wound internal item and/or body structure visible value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.11.json | Wound exudate appearance value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.12.json | Wound exudate color value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.13.json | Exudate odor value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.16.json | Skin temperature value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.17.json | Skin color enumerated value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.18.json | Skin turgor value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.19.json | Skin and mucous membrane integrity value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.2.json | Periwound condition value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.20.json | Skin moisture value set (foundation metadata concept) | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.3.json | Wound Type Etiology value set | active | 2024-06 | hl7 | sct | |||
| us.nlm.vsac | R4 | ValueSet-2.16.840.1.113762.1.4.1181.4.json | Wound episode value set (foundation metadata concept) | active | 2024-06 | hl7 | sct |
FHIR
FHIRsmith